To what extent do people living with HIV, people on pre-exposure prophylaxis, doctors and pharmacists endorse 90-day dispensing of antiretroviral therapy in France?
Christine JacometÉmilie GoncalvesCéline LambertDidier ChedorgeSylvia Puglièse-WehrlenÉric BillaudDavid ZucmanAnne SimonCédric ArvieuxHervé TroutBruno LaurandinRené MaarekIsabelle RaymondPascal PuglièseJulie LangloisAgnès CertainPublished in: PloS one (2022)
A clear majority of PLHIV, people on PrEP, doctors, and pharmacists endorsed 90D of ART. Most patients thought that 90D would be a good option, whereas most pharmacists and doctors thought that eligibility for 90D dispensing should depend on immunovirologic factors and social condition criteria. Moreover, pharmacists thought it would be necessary to commit regulatory resources and a better follow-up on adherence and drug-drug interactions.
Keyphrases
- antiretroviral therapy
- end stage renal disease
- hiv infected
- general practice
- medical students
- ejection fraction
- chronic kidney disease
- newly diagnosed
- human immunodeficiency virus
- mental health
- prognostic factors
- peritoneal dialysis
- emergency department
- men who have sex with men
- type diabetes
- hiv infected patients
- metabolic syndrome
- adipose tissue
- south africa
- insulin resistance
- weight loss
- electronic health record